<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0212672</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-23169</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Lung and intrathoracic tumors</subject><subj-group><subject>Non-small cell lung cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and neoplasms</subject><subj-group><subject>Carcinomas</subject><subj-group><subject>Adenocarcinomas</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Radiology and imaging</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Cancer detection and diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer detection and diagnosis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Surgical and invasive medical procedures</subject><subj-group><subject>Biopsy</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Mutagenesis and gene deletion techniques</subject><subj-group><subject>Mutational analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Mutagenesis and gene deletion techniques</subject><subj-group><subject>Mutational analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Endocrinology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Epidermal growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Epidermal growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Endocrine physiology</subject><subj-group><subject>Growth factors</subject><subj-group><subject>Epidermal growth factor</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Molecular analysis of small tissue samples obtained via transbronchial lung biopsy using radial probe endobronchial ultrasound</article-title>
<alt-title alt-title-type="running-head">Mutational analysis using small samples</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Insu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Eom</surname>
<given-names>Jung Seop</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Ah rong</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Chang Hun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Geewon</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jo</surname>
<given-names>Eun Jung</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Mi-Hyun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mok</surname>
<given-names>Jeong Ha</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Kwangha</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kim</surname>
<given-names>Ki Uk</given-names>
</name>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Park</surname>
<given-names>Hye-Kyung</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Min Ki</given-names>
</name>
<role content-type="http://credit.casrai.org/">Supervision</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Biomedical Research Institute, Pusan National University Hospital, Busan, Korea</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Pathology, Pusan National University School of Medicine, Busan, Korea</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Radiology, Pusan National University School of Medicine, Busan, Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Mascaux</surname>
<given-names>Céline</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Aix-Marseille Universite, FRANCE</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">ejspulm@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>14</volume>
<issue>2</issue>
<elocation-id>e0212672</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Kim et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0212672"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Radial probe endobronchial ultrasound using a guide sheath (EBUS-GS) is used to diagnose peripheral lung cancer. The aim was to identify the accuracy of molecular analysis that were performed with EBUS-GS specimens in patients with non-small cell lung cancer (NSCLC).</p>
</sec>
<sec id="sec002">
<title>Method</title>
<p>From December 2015 to September 2017, we retrospectively studied 91 patients with peripheral NSCLC who underwent surgery after EBUS-GS. Epidermal growth factor receptor (<italic>EGFR</italic>) mutational and anaplastic lymphoma kinase (<italic>ALK</italic>) translocation status obtained from surgical specimens served as the references.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Compared to the reference data, <italic>EGFR</italic> mutational testing of EBUS-GS specimens was in 97% agreement, and the κ coefficient was 0.931 (P&lt; 0.001). In addition, on <italic>ALK</italic> translocation testing, the results of all 91 patients were in agreement with the reference data (concordance rate of 100%, κ coefficient 1.000; P&lt; 0.001).</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>We found that EBUS-GS could be used for molecular diagnosis, such as <italic>EGFR</italic> mutational and <italic>ALK</italic> translocation status, in patients with peripheral NSCLC.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The authors received no specific funding for this work.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="3"/>
<page-count count="10"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Lung cancer is the leading cause of cancer-related death worldwide [<xref ref-type="bibr" rid="pone.0212672.ref001">1</xref>]. In recent years, significant developments in the diagnosis and treatment of non-small cell lung cancer (NSCLC) have been made [<xref ref-type="bibr" rid="pone.0212672.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0212672.ref003">3</xref>]. In particular, patient-tailored therapies with epidermal growth factor receptor (<italic>EGFR</italic>) tyrosine kinase inhibitors and anaplastic lymphoma kinase (<italic>ALK</italic>) inhibitors have improved progression-free survival in patients with inoperable NSCLC [<xref ref-type="bibr" rid="pone.0212672.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0212672.ref008">8</xref>].</p>
<p>Patient-tailored therapy requires accurate molecular data, which in turn means that appropriate tissue must be acquired. It is ideal to harvest as much tissue as possible for use in pathologic evaluation and molecular testing. In addition, the remaining tissue should be preserved for further testing [<xref ref-type="bibr" rid="pone.0212672.ref009">9</xref>]. However, due to technical problems with tissue testing, there is a limit to the amount of tissue that can be harvested. [<xref ref-type="bibr" rid="pone.0212672.ref010">10</xref>]. To date, three lung biopsy modalities (surgical wedge resection, percutaneous core needle biopsy [PCNB], and bronchoscopy) have been used for both molecular analysis and histological confirmation [<xref ref-type="bibr" rid="pone.0212672.ref011">11</xref>]. Generally, a prompt and definitive diagnosis using a large amount of tissue can be made on video-assisted thoracoscopic wedge resection under general anesthesia; however, the mortality rate is 0.5% and the complications include persistent air leakage and pneumonia [<xref ref-type="bibr" rid="pone.0212672.ref012">12</xref>]. In addition, although PCNB has afforded good diagnostic performance over many decades, the procedure-related complications include iatrogenic pneumothorax, pleural seeding, and bleeding [<xref ref-type="bibr" rid="pone.0212672.ref013">13</xref>].</p>
<p>Peripheral bronchoscopic techniques, including virtual and electromagnetic navigation, and radial probe endobronchial ultrasound (EBUS) using a guide sheath (GS), have developed rapidly, and are now used to diagnose peripheral lung nodules [<xref ref-type="bibr" rid="pone.0212672.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0212672.ref016">16</xref>]. Recently, transbronchial lung biopsy using a radial probe EBUS and a GS (EBUS-GS) has been shown to afford an acceptable diagnostic yield with a low complication rate [<xref ref-type="bibr" rid="pone.0212672.ref017">17</xref>,<xref ref-type="bibr" rid="pone.0212672.ref018">18</xref>]. However, the accuracy and reliability of molecular analyses of EBUS-GS specimens remain unclear. We retrospectively explored the accuracy of <italic>EGFR</italic> mutational and <italic>ALK</italic> translocation testing in small EBUS-GS tissue samples.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec007">
<title>Study population</title>
<p>Between December 2015 and September 2017, we retrospectively accessed the database of the EBUS-GS registry to explore the accuracies of <italic>EGFR</italic> mutational analysis and <italic>ALK</italic> fluorescence in situ hybridization (FISH) status performed on EBUS-GS specimens at Pusan National University Hospital (a university-affiliated, tertiary referral hospital in Busan, South Korea). During the study period, 97 consecutive patients who underwent surgical resection of peripheral NSCLC after a definitive histological EBUS-GS diagnosis were prospectively registered. When evaluating the mutational analyses, the surgical specimens served as the reference samples. Some of our clinical data included previous study conducted but not published [<xref ref-type="bibr" rid="pone.0212672.ref019">19</xref>]. Because of the retrospective nature of the study, the Institutional Review Board of Pusan National University Hospital approved this work without a requirement to obtain informed consent from each subject (approval no. 1711-023-061).</p>
</sec>
<sec id="sec008">
<title>EBUS-GS procedure</title>
<p>Before each procedure, 4% lidocaine was sprayed into the oropharynx to create local anesthesia and the patient was sedated with intravenous midazolam and fentanyl. First, conventional bronchoscopy using a thin, 4-mm flexible bronchoscope (BF-P260F; Olympus, Tokyo, Japan) was performed to examine the bronchial tree. Next, the bronchoscope was moved as close as possible to the bronchus of interest, guided by the thin-section chest computed tomography (CT) image (0.625mm in both interval and thickness). Then, a radial probe EBUS (UM-S20-17S; Olympus) covered with a GS (K-201; Olympus) was advanced through a 2.0-mm-diameter working channel of the thin bronchoscope to target the peripheral lung lesion precisely. Once the lesion had been accurately identified, the radial probe EBUS was withdrawn, leaving the GS in place to allow brush cytology and forceps biopsy under fluoroscopic guidance [<xref ref-type="bibr" rid="pone.0212672.ref020">20</xref>–<xref ref-type="bibr" rid="pone.0212672.ref023">23</xref>]. Neither virtual bronchoscopy nor electromagnetic navigation was employed [<xref ref-type="bibr" rid="pone.0212672.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0212672.ref015">15</xref>].</p>
</sec>
<sec id="sec009">
<title>Molecular analyses</title>
<p>Both <italic>EGFR</italic> mutation and <italic>ALK</italic> FISH tests were performed using biopsy tissue and surgically resected samples. <italic>EGFR</italic> mutational tests were performed using an <italic>EGFR</italic> Mutation Detection Kit (PNA clamp; Panagene, Daejeon, South Korea) [<xref ref-type="bibr" rid="pone.0212672.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0212672.ref025">25</xref>]. A commercial <italic>ALK</italic> FISH assay (Vysis <italic>ALK</italic> Break Apart FISH Probe Kit; Abbott Laboratories, Lake Bluff, IL, USA) was used to detect <italic>ALK</italic> translocation [<xref ref-type="bibr" rid="pone.0212672.ref026">26</xref>,<xref ref-type="bibr" rid="pone.0212672.ref027">27</xref>].</p>
</sec>
<sec id="sec010">
<title>Procedure-related complications</title>
<p>Four hours after EBUS-GS, a plain chest film was taken to detect any procedure-related complication including iatrogenic pneumothorax, and a follow-up chest radiograph was taken the next morning. Severe procedure-related bleeding was defined as a need for intubation, radiological intervention, or transfusion. Any complication such as respiratory failure or pulmonary infection was recorded.</p>
</sec>
<sec id="sec011">
<title>Statistical analysis</title>
<p>Data are presented as numbers (%) or medians (interquartile ranges [IQRs]) as appropriate. The extents of agreement between <italic>EGFR</italic> mutational tests and <italic>ALK</italic> FISH analyses (EBUS-GS vs. surgical specimens) were determined using Cohen’s κ statistic [<xref ref-type="bibr" rid="pone.0212672.ref028">28</xref>,<xref ref-type="bibr" rid="pone.0212672.ref029">29</xref>]. A two-sided P-value &lt;0.05 was considered to indicate statistical significance. All statistical analyses were conducted using SPSS version 22.0 software for Windows (SPSS Inc., Chicago, IL, USA).</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Patients</title>
<p>Of the 97 patients who underwent surgical resection of peripheral NSCLC after definitive diagnosis using EBUS-GS, 6 were excluded because their molecular analyses were incomplete. The baseline characteristics of the 91 subjects are shown <xref ref-type="table" rid="pone.0212672.t001">Table 1</xref>. A total of 54 patients were male (59%), and the median age was 67 years (IQR, 60–72 years). The pathological diagnosis was as follows: adenocarcinoma in 68 patients (75%), squamous cell carcinoma in 18 (20%), and NSCLC not otherwise specified in 5 (5%).</p>
<table-wrap id="pone.0212672.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.t001</object-id>
<label>Table 1</label> <caption><title>Baseline characteristics of 91 patients who underwent surgical resection after EBUS-GS.</title></caption>
<alternatives>
<graphic id="pone.0212672.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify">Characteristic</th>
<th align="center">No. (%) or median (interquartile range)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Age, years</td>
<td align="center">67 (60–72)</td>
</tr>
<tr>
<td align="left">Male gender</td>
<td align="center">54 (59)</td>
</tr>
<tr>
<td align="left">Ever-smoker</td>
<td align="center">45 (50)</td>
</tr>
<tr>
<td align="left">Pathological diagnosis</td>
<td align="center"/>
</tr>
<tr>
<td align="left">    Adenocarcinoma</td>
<td align="center">68 (75)</td>
</tr>
<tr>
<td align="left">    Squamous cell carcinoma</td>
<td align="center">18 (20)</td>
</tr>
<tr>
<td align="left">    Non-small cell lung cancer, NOS</td>
<td align="center">5 (5)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>EBUS-GS = endobronchial ultrasound using a guide sheath; NOS = not otherwise specified.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Molecular analysis</title>
<p>Using the EBUS-GS and surgical specimens, <italic>EGFR</italic> mutations were detected in 35 and 38 patients, respectively (38 and 42%). The results differed in three patients (3%) (<xref ref-type="fig" rid="pone.0212672.g001">Fig 1</xref>). The agreement rate was 97% and the κ coefficient was 0.931 (P&lt; 0.001) (<xref ref-type="table" rid="pone.0212672.t002">Table 2</xref>). In the <italic>ALK</italic> FISH test, 5 of 91 patients (5%) were positive on both surgical and EBUS-GS testing (<xref ref-type="fig" rid="pone.0212672.g002">Fig 2</xref>). The agreement rate was 100% and the κ coefficient was 1.000 (P&lt; 0.001) (<xref ref-type="table" rid="pone.0212672.t002">Table 2</xref>). Additional statistical analysis was performed except for squamous cell carcinoma patients. In 73 patients, the agreement rate of EGFR mutation was 96% and the κ coefficient was 0.918 (<italic>P</italic> = 0.046). In the ALK FISH test, agreement rate was 100% and the κ coefficient was 1.000 (<italic>P</italic>&lt; 0.001).</p>
<fig id="pone.0212672.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Comparison of <italic>EGFR</italic> mutational analysis between the EBUS-GS and surgical specimens.</title>
<p>EBUS-GS = endobronchial ultrasound using a guide sheath; <italic>EGFR</italic> = epidermal growth factor receptor.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.g001" xlink:type="simple"/>
</fig>
<fig id="pone.0212672.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Comparison of <italic>ALK</italic> translocation analysis between the EBUS-GS and surgical specimens.</title>
<p>EBUS-GS = endobronchial ultrasound using a guide sheath; <italic>ALK</italic> = anaplastic lymphoma kinase.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0212672.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.t002</object-id>
<label>Table 2</label> <caption><title>Comparisons of the <italic>EGFR</italic> mutational and <italic>ALK</italic> translocation results between the EBUS-GS and surgical specimens.</title></caption>
<alternatives>
<graphic id="pone.0212672.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify"/>
<th align="center" colspan="2">Specimens</th>
<th align="center" colspan="3">Correlation analysis</th>
</tr>
<tr>
<th align="justify"/>
<th align="center">EBUS-GS (%)</th>
<th align="center">Surgery (%)</th>
<th align="center">Agreement rate</th>
<th align="center">κ coefficient</th>
<th align="center"><italic>P</italic> value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><italic>EGFR</italic> mutation detected</td>
<td align="center">35/91 (38)</td>
<td align="center">38/91 (42)</td>
<td align="center">97%</td>
<td align="center">0.931</td>
<td align="center">&lt;0.001</td>
</tr>
<tr>
<td align="left"><italic>ALK</italic>-positive</td>
<td align="center">5/91 (5)</td>
<td align="center">5/91 (5)</td>
<td align="center">100%</td>
<td align="center">1.000</td>
<td align="center">&lt; 0.001</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p><italic>EGFR</italic> = epidermal growth factor receptor; <italic>ALK</italic> = anaplastic lymphoma kinase; EBUS-GS = endobronchial ultrasound using a guide sheath.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Procedure-related complications</title>
<p>Only one patient (1%) developed procedure-related pneumothorax, but recovered spontaneously without chest tube insertion. No other complications were observedno severe hemorrhage, pulmonary infection, or respiratory failure was noted.</p>
</sec>
<sec id="sec016">
<title>Disagreements in <italic>EGFR</italic> mutational analysis</title>
<p>All three patients with inconsistent <italic>EGFR</italic> mutational results were pathologically diagnosed with adenocarcinomas. Compared to the EBUS-GS specimens that yielded correct results, the tumor cell numbers estimated by pathologists were lower on hematoxylin-and-eosin-stained slides of all incorrectly diagnosed EBUS-GS specimens. Moreover, only a few thyroid transcription factor-1-stained cells were observed in two of these EBUS-GS specimens (<xref ref-type="fig" rid="pone.0212672.g003">Fig 3A and 3B</xref>); one specimen could not be stained because the available tissue was insufficient (Case No. 2, <xref ref-type="table" rid="pone.0212672.t003">Table 3</xref>). Higher numbers of thyroid transcription factor-1-and hematoxylin-and-eosin-stained cells were observed, at the same magnification, in EBUS-GS specimens that were correctly diagnosed (<xref ref-type="fig" rid="pone.0212672.g003">Fig 3C and 3D</xref>).</p>
<fig id="pone.0212672.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Comparison of an EBUS-GS specimen yielding false-negative <italic>EGFR</italic> results and a specimen yielding correct <italic>EGFR</italic> results.</title>
<p>(A) A few adenocarcinoma cells were clustered in the EBUS-GS specimen with the false-negative <italic>EGFR</italic> result (H&amp;E stain, ×400). (B) The EBUS-GS specimen with false-negative <italic>EGFR</italic> result was weakly immunoactive for TTF-1 (×400). (C) Larger numbers of tumor cells were evident in the specimen yielding correct <italic>EGFR</italic> results (H&amp;E stain, ×400). (D) The EBUS-GS specimen with correct <italic>EGFR</italic> result was strongly immunoactive for TTF-1(×400). EBUS-GS = endobronchial ultrasound using a guide sheath; <italic>EGFR</italic> = epidermal growth factor receptor; TTF-1 = thyroid transcription factor-1.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.g003" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0212672.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0212672.t003</object-id>
<label>Table 3</label> <caption><title>Cases with discordant <italic>EGFR</italic> mutational results between the EBUS-GS and surgical specimens.</title></caption>
<alternatives>
<graphic id="pone.0212672.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Case No.</th>
<th align="center">Age, years</th>
<th align="center">Sex</th>
<th align="center">Pathology</th>
<th align="center">Lesion size, mm<xref ref-type="table-fn" rid="t003fn002"><sup>a</sup></xref></th>
<th align="center">Location</th>
<th align="center">Bronchus sign</th>
<th align="center">Probe location</th>
<th align="center">TTF-1 IHC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">1</td>
<td align="center">78</td>
<td align="center">Male</td>
<td align="center">ADC</td>
<td align="center">36</td>
<td align="center">RLL</td>
<td align="center">Positive</td>
<td align="center">Adjacent to tumor</td>
<td align="center">Positive</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">74</td>
<td align="center">Female</td>
<td align="center">ADC</td>
<td align="center">48</td>
<td align="center">RUL</td>
<td align="center">Positive</td>
<td align="center">Within tumor</td>
<td align="center">Insufficient<xref ref-type="table-fn" rid="t003fn003"><sup>b</sup></xref></td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">70</td>
<td align="center">Female</td>
<td align="center">ADC</td>
<td align="center">38</td>
<td align="center">RML</td>
<td align="center">Positive</td>
<td align="center">Within tumor</td>
<td align="center">Positive</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p><italic>EGFR</italic>, epidermal growth factor receptor; EBUS-GS, endobronchial ultrasound using a guide sheath; TTF-1, thyroid transcription factor-1; IHC, immunohistochemistry; ADC, adenocarcinoma; RLL, right lower lobe; RUL, right upper lobe; RML, right middle lobe.</p></fn>
<fn id="t003fn002"><p><sup>a</sup> Largest tumor diameter.</p></fn>
<fn id="t003fn003"><p><sup>b</sup> Insufficient EBUS-GS material for TTF-1 staining</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<p>We found that EBUS-GS afforded very accurate <italic>EGFR</italic> mutational and <italic>ALK</italic> FISH diagnoses in NSCLC patients. To the best of our knowledge, this is the first report on the accuracy of molecular diagnosis using such specimens. In the 91 NSCLC patients, the accuracies of the <italic>EGFR</italic> mutational and <italic>ALK</italic> translocation tests were 97% and 100%, respectively. Our findings imply that appropriate decision-making in terms of anti-cancer drug selection (<italic>EGFR</italic> tyrosine kinase inhibitors, <italic>ALK</italic> inhibitors, or intravenous cytotoxic chemotherapy) is possible based on molecular data obtained from EBUS-GS specimens of patients with advanced NSCLC.</p>
<p>Tam <italic>et al</italic>. found that 83% of PCNB samples were suitable for molecular testing in 151 patients with NSCLC [<xref ref-type="bibr" rid="pone.0212672.ref030">30</xref>]. However, procedure-related complications occurred in 16% of the patients, of whom 57% required chest tube insertion to manage iatrogenic pneumothorax. Vanderlaan <italic>et al</italic>. reported that the accuracy of molecular analysis using PCNB samples was lower than noted in a previous study [<xref ref-type="bibr" rid="pone.0212672.ref031">31</xref>]; the accuracies of <italic>EGFR</italic> mutational and <italic>ALK</italic> FISH tests performed on PCNB samples were 68% and 65%, respectively, in 22 patients with NSCLC. Chen <italic>et al</italic>. found that all PCNB samples examined could be used for <italic>EGFR</italic> mutational testing [<xref ref-type="bibr" rid="pone.0212672.ref032">32</xref>]. However, this study feature relatively small group of 17 patients, and complications such as pneumothorax (18%) and hemoptysis (12%) were relatively common. In summary, although molecular diagnosis using PCNB samples is reliable, the incidence of procedure-related complications, such as iatrogenic pneumothorax, is relatively high.</p>
<p>In contrast, Steinfort <italic>et al</italic>. showed that EBUS-GS afforded similar pathological diagnostic accuracy compared with PCNB (87.5% vs. 93.3%, respectively) and good sensitivity (86% vs.92%, respectively), associated with considerably fewer procedure-related complications (3%vs. 27%, respectively) [<xref ref-type="bibr" rid="pone.0212672.ref033">33</xref>]. Hamaya <italic>et al</italic>. reported that the overall complication rate of EBUS-GS (pneumothorax or pneumonia) was 1.3% in 965 study subjects [<xref ref-type="bibr" rid="pone.0212672.ref017">17</xref>]. In the present study, the accuracies of <italic>EGFR</italic> mutational and <italic>ALK</italic> FISH testing were 97% and 100%, and the overall complication rate was only 1%. Thus, EBUS-GS is safe and reliable, and the tissue samples can be used for both pathological and molecular analyses.</p>
<p>Generally, molecular analysis proceeds using the tissue that remains after histological examination featuring hematoxylin-and-eosin staining. Therefore, molecular tests are usually performed employing less tissue than in histological examinations and molecular analysis of a small biopsy sample, such as that of PCNB or EBUS-GS, could yield false-negative results because of insufficient tumor tissue or a low tumor fraction. Eberhard <italic>et al</italic>. suggested that the tumor sectional area should be ≥1–2mm, except in non-tumor areas [<xref ref-type="bibr" rid="pone.0212672.ref034">34</xref>]. In addition, in terms of cell counts, &gt;100 tumor cell nuclei should be assessed in terms of FISH. Lindeman <italic>et al</italic>. recommended that mutated cells should constitute ≥20% of all cells when <italic>EGFR</italic> mutational and <italic>ALK</italic> translocation statuses are evaluated [<xref ref-type="bibr" rid="pone.0212672.ref035">35</xref>]. In the present study, false-negative <italic>EGFR</italic> mutational data were obtained from three EBUS-GS specimens (3%). The tumor cell numbers in these specimens were lower than those of other specimens. Thus, insufficient tumor tissue available after histological examination explained the false-negative results. If the <italic>EGFR</italic> mutational status of an EBUS-GS specimen is negative, a false-negative should be considered when the sample volume is small, particularly if the patient is at risk of <italic>EGFR</italic> or <italic>ALK</italic> mutation (has an adenocarcinoma, is a female East Asian, or is a never-smoker) [<xref ref-type="bibr" rid="pone.0212672.ref036">36</xref>–<xref ref-type="bibr" rid="pone.0212672.ref039">39</xref>].</p>
<p>Our study had several limitations. First, although we used an EBUS-GS registry, selection bias may have occurred. Second, this was a single-center study with a relatively small number of subjects; our results can thus not be generalized to other institutions or geographical areas. Third, as we used data from surgical specimens as references, only patients with early-stage lung cancer who underwent surgery were included. Molecular analyses, such as <italic>EGFR</italic> mutational and <italic>ALK</italic> FISH tests, are required by patients with advanced NSCLC to guide the selection of anti-cancer drugs (<italic>EGFR</italic> tyrosine kinase or <italic>ALK</italic> inhibitors). Generally, patients with advanced NSCLC requiring molecular analysis have larger and more tumors than patients with early-stage lung cancer. Previous studies found that the accuracy of EBUS-GS evaluation was associated with lesion size [<xref ref-type="bibr" rid="pone.0212672.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0212672.ref016">16</xref>,<xref ref-type="bibr" rid="pone.0212672.ref040">40</xref>]. Therefore, the accuracy of molecular diagnosis would be expected to be higher in actual clinical practice. Fourth, NGS data were unavailable in the present study. However, the sensitivity and specificity of PNA clamping are 97% and 100%, respectively, similar to the respective values of 95.83% and 98.11% for NGS [<xref ref-type="bibr" rid="pone.0212672.ref041">41</xref>–<xref ref-type="bibr" rid="pone.0212672.ref043">43</xref>]. If NGS is available for both small biopsy samples and surgical specimens, it is possible to compare the concordance of various kinds of mutational analyses. Fifth, given the retrospective nature of this study, it was not possible to quantitatively analyze the effect of sample volume on the molecular data. Generally, the cellularity of the specimen is important for interpretation of mutation analysis results [<xref ref-type="bibr" rid="pone.0212672.ref044">44</xref>]. Recent guidelines recommend mutation analysis of samples with an at-least 20% malignant cell content [<xref ref-type="bibr" rid="pone.0212672.ref035">35</xref>]. To address these issues, an additional prospective multicenter study with a large number of patients that incorporates methods to evaluate cellularity is needed.</p>
</sec>
<sec id="sec018" sec-type="conclusions">
<title>Conclusion</title>
<p>The results of EGFR mutation and ALK gene rearrangement tests on EBUS-GS samples showed good agreement with those on surgical specimens of NSCLC patients.</p>
</sec>
<sec id="sec019">
<title>Supporting information</title>
<supplementary-material id="pone.0212672.s001" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pone.0212672.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Clinical data of total patients.</title>
<p>ADC, adenocarcinoma; SqCC, squamous cell carcinoma; NSCLC, non-small cell lung cancer; ALK, anaplastic lymphoma kinase; EGFR, epidermal growth factor receptor; RLL, right lower lobe; RUL, right upper lobe; LUL, left upper lobe; LLL, left lower lobe; RML, right middle lobe.</p>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0212672.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegel</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Jemal</surname> <given-names>A</given-names></name>.<article-title>Cancer statistics, 2016</article-title>. <source>CA Cancer JClin</source>.<year>2016</year>; <volume>66</volume>: <fpage>7</fpage>–<lpage>30</lpage>.</mixed-citation></ref>
<ref id="pone.0212672.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reck</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Heigener</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Mok</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Soria</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Rabe</surname> <given-names>KF</given-names></name>. <article-title>Management of non-small-cell lung cancer: recent developments</article-title>. <source>Lancet</source>. <year>2013</year>; <volume>382</volume>: <fpage>709</fpage>–<lpage>19</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(13)61502-0" xlink:type="simple">10.1016/S0140-6736(13)61502-0</ext-link></comment> <object-id pub-id-type="pmid">23972814</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreira</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Eng</surname> <given-names>J</given-names></name>. <article-title>Personalized therapy for lung cancer</article-title>. <source>Chest</source>. <year>2014</year>; <volume>146</volume>: <fpage>1649</fpage>–<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1378/chest.14-0713" xlink:type="simple">10.1378/chest.14-0713</ext-link></comment> <object-id pub-id-type="pmid">25451351</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosell</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Carcereny</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gervais</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Vergnenegre</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Massuti</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Felip</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced <italic>EGFR</italic> mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial</article-title>. <source>Lancet Oncol</source>. <year>2012</year>; <volume>13</volume>: <fpage>239</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(11)70393-X" xlink:type="simple">10.1016/S1470-2045(11)70393-X</ext-link></comment> <object-id pub-id-type="pmid">22285168</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mok</surname> <given-names>TS</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Thongprasert</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Chu</surname> <given-names>DT</given-names></name>, <name name-style="western"><surname>Saijo</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma</article-title>. <source>N Engl J Med</source>. <year>2009</year>; <volume>361</volume>: <fpage>947</fpage>–<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa0810699" xlink:type="simple">10.1056/NEJMoa0810699</ext-link></comment> <object-id pub-id-type="pmid">19692680</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Schuler</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sebastian</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Popat</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Afatinib versus cisplatin-based chemotherapy for <italic>EGFR</italic> mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials</article-title>. <source>Lancet Oncol</source>. <year>2015</year>; <volume>16</volume>: <fpage>141</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(14)71173-8" xlink:type="simple">10.1016/S1470-2045(14)71173-8</ext-link></comment> <object-id pub-id-type="pmid">25589191</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Solomon</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Mok</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Nakagawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mekhail</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>First-line crizotinib versus chemotherapy in <italic>ALK</italic>-positive lung cancer</article-title>. <source>N Engl J Med</source>. <year>2014</year>; <volume>371</volume>: <fpage>2167</fpage>–<lpage>77</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1408440" xlink:type="simple">10.1056/NEJMoa1408440</ext-link></comment> <object-id pub-id-type="pmid">25470694</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Saijo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Thongprasert</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Margono</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with <italic>EGFR</italic> mutation-positive advanced NSCLC</article-title>. <source>Lung Cancer</source>. <year>2017</year>; <volume>104</volume>: <fpage>119</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lungcan.2016.11.022" xlink:type="simple">10.1016/j.lungcan.2016.11.022</ext-link></comment> <object-id pub-id-type="pmid">28212993</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Travis</surname> <given-names>WD</given-names></name>, <name name-style="western"><surname>Brambilla</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Noguchi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nicholson</surname> <given-names>AG</given-names></name>, <name name-style="western"><surname>Geisinger</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yatabe</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification</article-title>. <source>Arch Pathol Lab Med</source>. <year>2013</year> <month>May</month>;<volume>137</volume>(<issue>5</issue>):<fpage>668</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5858/arpa.2012-0263-RA" xlink:type="simple">10.5858/arpa.2012-0263-RA</ext-link></comment> <object-id pub-id-type="pmid">22970842</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reck</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hermes</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>EH</given-names></name>, <name name-style="western"><surname>Felip</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Klughammer</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Baselga</surname> <given-names>J</given-names></name>. <article-title>Tissue sampling in lung cancer: a review in light of the MERIT experience</article-title>. <source>Lung Cancer</source>. <year>2011</year> <month>Oct</month>;<volume>74</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lungcan.2011.05.002" xlink:type="simple">10.1016/j.lungcan.2011.05.002</ext-link></comment> <object-id pub-id-type="pmid">21658788</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gould</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Donington</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lynch</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Mazzone</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Midthun</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Naidich</surname> <given-names>DP</given-names></name>, <etal>et al</etal>. <article-title>Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines</article-title>. <source>Chest</source>. <year>2013</year>; <volume>143</volume>: <fpage>e93S</fpage>–<lpage>120S</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1378/chest.12-2351" xlink:type="simple">10.1378/chest.12-2351</ext-link></comment> <object-id pub-id-type="pmid">23649456</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rivera</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Mehta</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Wahidi</surname> <given-names>MM</given-names></name>. <article-title>Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines</article-title>. <source>Chest</source>. <year>2013</year>; <volume>143</volume>: <fpage>e142S</fpage>–<lpage>e65S</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1378/chest.12-2353" xlink:type="simple">10.1378/chest.12-2353</ext-link></comment> <object-id pub-id-type="pmid">23649436</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Hsiao</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Shih</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation</article-title>. <source>J Thorac Oncol</source>. <year>2012</year>; <volume>7</volume>: <fpage>143</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/JTO.0b013e318233d7dd" xlink:type="simple">10.1097/JTO.0b013e318233d7dd</ext-link></comment> <object-id pub-id-type="pmid">22124475</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eberhardt</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Anantham</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ernst</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Feller-Kopman</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Herth</surname> <given-names>F</given-names></name>. <article-title>Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial</article-title>. <source>Am J Respir Crit Care Med</source>.<year>2007</year>; <volume>176</volume>: <fpage>36</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1164/rccm.200612-1866OC" xlink:type="simple">10.1164/rccm.200612-1866OC</ext-link></comment> <object-id pub-id-type="pmid">17379850</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ishida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Asano</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yamazaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shinagawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Oizumi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Moriya</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial</article-title>. <source>Thorax</source>. <year>2011</year>; <volume>66</volume>: <fpage>1072</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/thx.2010.145490" xlink:type="simple">10.1136/thx.2010.145490</ext-link></comment> <object-id pub-id-type="pmid">21749984</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kurimoto</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Miyazawa</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Okimasa</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Maeda</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Oiwa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Miyazu</surname> <given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically</article-title>. <source>Chest</source>. <year>2004</year>; <volume>126</volume>: <fpage>959</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1378/chest.126.3.959" xlink:type="simple">10.1378/chest.126.3.959</ext-link></comment> <object-id pub-id-type="pmid">15364779</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hayama</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Izumo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Matsumoto</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Chavez</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tsuchida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sasada</surname> <given-names>S</given-names></name>. <article-title>Complications with endobronchial ultrasound with a guide sheath for the diagnosis of peripheral pulmonary Lesions</article-title>. <source>Respiration</source>. <year>2015</year>; <volume>90</volume>: <fpage>129</fpage>–<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000431383" xlink:type="simple">10.1159/000431383</ext-link></comment> <object-id pub-id-type="pmid">26112297</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steinfort</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Khor</surname> <given-names>YH</given-names></name>, <name name-style="western"><surname>Manser</surname> <given-names>RL</given-names></name>, <name name-style="western"><surname>Irving</surname> <given-names>LB</given-names></name>. <article-title>Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis</article-title>. <source>Eur Respir J</source>. <year>2011</year>; <volume>37</volume>: <fpage>902</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.00075310" xlink:type="simple">10.1183/09031936.00075310</ext-link></comment> <object-id pub-id-type="pmid">20693253</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eom</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Mok</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Radial probe endobronchial ultrasound using a guide sheath for peripheral lung lesions in beginners</article-title>. <source>unpublish data</source>.</mixed-citation></ref>
<ref id="pone.0212672.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shinagawa</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yamada</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Asahina</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kikuchi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Oizumi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kurimoto</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Transbronchial biopsy for peripheral pulmonary lesions under real-time endobronchial ultrasonographic guidance</article-title>. <source>J Bronchology Interv Pulmonol</source>. <year>2009</year>; <volume>16</volume>: <fpage>261</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/LBR.0b013e3181bb8058" xlink:type="simple">10.1097/LBR.0b013e3181bb8058</ext-link></comment> <object-id pub-id-type="pmid">23168590</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kikuchi</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Yamazaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sukoh</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Kikuchi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Asahina</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Imura</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions</article-title>. <source>Eur Respir J</source>. <year>2004</year>; <volume>24</volume>: <fpage>533</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1183/09031936.04.00138603" xlink:type="simple">10.1183/09031936.04.00138603</ext-link></comment> <object-id pub-id-type="pmid">15459129</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonney</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Christie</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Beaty</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lunke</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Irving</surname> <given-names>L</given-names></name>, <article-title>el al. The feasibility of molecular testing on cell blocks created from brush tip washings in the assessment of peripheral lung lesions</article-title>. <source>J Thorac Dis</source>. <year>2016</year> <month>Sep</month>; <volume>8</volume>(<issue>9</issue>): <fpage>2551</fpage>–<lpage>2555</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21037/jtd.2016.08.85" xlink:type="simple">10.21037/jtd.2016.08.85</ext-link></comment> <object-id pub-id-type="pmid">27747008</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonney</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Beaty</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>See</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Irving</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Steinfort</surname> <given-names>D</given-names></name>. <article-title>Diagnostic Utility of Bronchial Brush-Tip Washings for the Immunohistochemical Assessment of Peripheral Lung Lesions</article-title>. <source>Acta Cytol</source>. <year>2016</year>; <volume>60</volume>(<issue>1</issue>): <fpage>74</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000444044" xlink:type="simple">10.1159/000444044</ext-link></comment> <object-id pub-id-type="pmid">26918654</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>HR</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Hyun</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>HK</given-names></name>, <name name-style="western"><surname>Choi</surname> <given-names>CM</given-names></name>, <etal>et al</etal>. <article-title>Detection of <italic>EGFR</italic> mutations in circulating free DNA by PNA-mediated PCR clamping</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2013</year>; <volume>32</volume>: <fpage>50</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1756-9966-32-50" xlink:type="simple">10.1186/1756-9966-32-50</ext-link></comment> <object-id pub-id-type="pmid">23927790</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yeo</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Rhee</surname> <given-names>CK</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>Detection and comparison of <italic>EGFR</italic> mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing</article-title>. <source>Lung Cancer</source>. <year>2013</year>; <volume>81</volume>: <fpage>207</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lungcan.2013.04.023" xlink:type="simple">10.1016/j.lungcan.2013.04.023</ext-link></comment> <object-id pub-id-type="pmid">23726527</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yi</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Boland</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Maleszewski</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Roden</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Oliveira</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Aubry</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title>Correlation of IHC and FISH for <italic>ALK</italic> gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH</article-title>. <source>J Thorac Oncol</source>. <year>2011</year>; <volume>6</volume>: <fpage>459</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/JTO.0b013e318209edb9" xlink:type="simple">10.1097/JTO.0b013e318209edb9</ext-link></comment> <object-id pub-id-type="pmid">21278610</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kwak</surname> <given-names>EL</given-names></name>, <name name-style="western"><surname>Bang</surname> <given-names>YJ</given-names></name>, <name name-style="western"><surname>Camidge</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Solomon</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Maki</surname> <given-names>RG</given-names></name>, <etal>et al</etal>. <article-title>Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer</article-title>. <source>N Engl J Med</source>. <year>2010</year>; <volume>363</volume>: <fpage>1693</fpage>–<lpage>703</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa1006448" xlink:type="simple">10.1056/NEJMoa1006448</ext-link></comment> <object-id pub-id-type="pmid">20979469</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McHugh</surname> <given-names>ML</given-names></name>. <article-title>Interrater reliability: the kappa statistic</article-title>. <source>Biochem Med</source>. <year>2012</year>; <volume>22</volume>: <fpage>276</fpage>–<lpage>82</lpage>.</mixed-citation></ref>
<ref id="pone.0212672.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>GG</given-names></name>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source>. <year>1977</year>; <volume>33</volume>: <fpage>159</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">843571</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tam</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Ensor</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Hicks</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial</article-title>. <source>J Thorac Oncol</source>. <year>2013</year>; <volume>8</volume>: <fpage>436</fpage>–<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/JTO.0b013e318287c91e" xlink:type="simple">10.1097/JTO.0b013e318287c91e</ext-link></comment> <object-id pub-id-type="pmid">23442309</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanderlaan</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Yamaguchi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Folch</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Boucher</surname> <given-names>DH</given-names></name>, <name name-style="western"><surname>Kent</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Gangadharan</surname> <given-names>SP</given-names></name>, <etal>et al</etal>. <article-title>Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer</article-title>. <source>Lung Cancer</source>. <year>2014</year>; <volume>84</volume>: <fpage>39</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.lungcan.2014.01.013" xlink:type="simple">10.1016/j.lungcan.2014.01.013</ext-link></comment> <object-id pub-id-type="pmid">24513263</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chen</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>JW</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>YC</given-names></name>, <name name-style="western"><surname>Lin</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Hsieh</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Hsu</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Computed tomography-guided core-needle biopsy specimens demonstrate epidermal growth factor receptor mutations in patients with non-small-cell lung cancer</article-title>. <source>ActaRadiol</source>. <year>2008</year>; <volume>49</volume>: <fpage>991</fpage>–<lpage>4</lpage>.</mixed-citation></ref>
<ref id="pone.0212672.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Steinfort</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Vincent</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Heinze</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Antippa</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Irving</surname> <given-names>LB</given-names></name>. <article-title>Comparative effectiveness of radial probe endobronchial ultrasound versus CT-guided needle biopsy for evaluation of peripheral pulmonary lesions: a randomized pragmatic trial</article-title>. <source>Respir Med</source>. <year>2011</year>; <volume>105</volume>: <fpage>1704</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.rmed.2011.08.008" xlink:type="simple">10.1016/j.rmed.2011.08.008</ext-link></comment> <object-id pub-id-type="pmid">21875783</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eberhard</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Giaccone</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>BE</given-names></name>. <article-title>Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting</article-title>. <source>J Clin Oncol</source>. <year>2008</year>; <volume>26</volume>: <fpage>983</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2007.12.9858" xlink:type="simple">10.1200/JCO.2007.12.9858</ext-link></comment> <object-id pub-id-type="pmid">18281673</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindeman</surname> <given-names>NI</given-names></name>, <name name-style="western"><surname>Cagle</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Aisner</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Arcila</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Beasley</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Bernicker</surname> <given-names>EH</given-names></name>, <etal>et al</etal>. <article-title>Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology</article-title>. <source>J Mol Diagn</source>. <year>2018</year> <month>Mar</month>; <volume>20</volume>(<issue>2</issue>):<fpage>129</fpage>–<lpage>159</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.jmoldx.2017.11.004" xlink:type="simple">10.1016/j.jmoldx.2017.11.004</ext-link></comment> <object-id pub-id-type="pmid">29398453</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sun</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ren</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Fang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases</article-title>. <source>J Clin Oncol</source>. <year>2010</year>; <volume>28</volume>: <fpage>4616</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2010.29.6038" xlink:type="simple">10.1200/JCO.2010.29.6038</ext-link></comment> <object-id pub-id-type="pmid">20855837</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Scagliotti</surname> <given-names>GV</given-names></name>, <name name-style="western"><surname>Longo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Novello</surname> <given-names>S</given-names></name>.<article-title>Non-small cell lung cancer in never smokers</article-title>. <source>Curr Opin Oncol</source>. <year>2009</year>; <volume>21</volume>: <fpage>99</fpage>–<lpage>104</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/CCO.0b013e328321049e" xlink:type="simple">10.1097/CCO.0b013e328321049e</ext-link></comment> <object-id pub-id-type="pmid">19532009</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shigematsu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gazdar</surname> <given-names>AF</given-names></name>. <article-title>Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers</article-title>. <source>Int J Cancer</source>. <year>2006</year>; <volume>118</volume>: <fpage>257</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.21496" xlink:type="simple">10.1002/ijc.21496</ext-link></comment> <object-id pub-id-type="pmid">16231326</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yatabe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Mitsudomi</surname> <given-names>T</given-names></name>. <article-title>Epidermal growth factor receptor mutations in lung cancers</article-title>. <source>Pathol Int</source>. <year>2007</year>; <volume>57</volume>: <fpage>233</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1440-1827.2007.02098.x" xlink:type="simple">10.1111/j.1440-1827.2007.02098.x</ext-link></comment> <object-id pub-id-type="pmid">17493170</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Xiang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Relationship between tumor size and disease stage in non-small cell lung cancer</article-title>. <source>BMC Cancer</source>. <year>2010</year>; <volume>10</volume>: <fpage>474</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2407-10-474" xlink:type="simple">10.1186/1471-2407-10-474</ext-link></comment> <object-id pub-id-type="pmid">20813054</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Jiang</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fei</surname> <given-names>K</given-names></name>. <article-title>Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing</article-title>. <source>Scand J Clin Lab Invest</source>. <year>2016</year> <month>Sep</month>; <volume>76</volume>(<issue>5</issue>): <fpage>386</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/00365513.2016.1183813" xlink:type="simple">10.1080/00365513.2016.1183813</ext-link></comment> <object-id pub-id-type="pmid">27215271</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jing</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Mao</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Next-generation sequencing-based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her-2 and TP53 mutations in patients with non-small cell lung cancer</article-title>. <source>Mol Med Rep</source>. <year>2018</year> <month>Aug</month>; <volume>18</volume>(<issue>2</issue>): <fpage>2191</fpage>–<lpage>2197</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/mmr.2018.9210" xlink:type="simple">10.3892/mmr.2018.9210</ext-link></comment> <object-id pub-id-type="pmid">29956783</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tanaka</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Nagai</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Miyazawa</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Koyama</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Matsuoka</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sutani</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers</article-title>. <source>Cancer Sci</source>. <year>2007</year> <month>Feb</month>; <volume>98</volume>(<issue>2</issue>): <fpage>246</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1349-7006.2006.00377.x" xlink:type="simple">10.1111/j.1349-7006.2006.00377.x</ext-link></comment> <object-id pub-id-type="pmid">17233841</object-id></mixed-citation></ref>
<ref id="pone.0212672.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>. <article-title>Sample types applied for molecular diagnosis of therapeutic management of advanced non-small cell lung cancer in the precision medicine</article-title>. <source>Clin Chem Lab Med</source>. <year>2017</year> <month>Oct</month> <day>26</day>;<volume>55</volume>(<issue>12</issue>):<fpage>1817</fpage>–<lpage>1833</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1515/cclm-2017-0112" xlink:type="simple">10.1515/cclm-2017-0112</ext-link></comment> <object-id pub-id-type="pmid">28493816</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>